Today: 13 June 2026
Diageo stock rises in London after Remy Cointreau surprise, with Feb results next test
30 January 2026
1 min read

Diageo stock rises in London after Remy Cointreau surprise, with Feb results next test

London, Jan 30, 2026, 09:25 GMT — Regular session underway

  • Shares of Diageo climbed roughly 2% in early trading in London, following Thursday’s close.
  • Traders noted a slight boost in spirits-sector sentiment following Rémy Cointreau’s quarterly sales beating expectations.
  • Diageo’s upcoming interim results, due on Feb. 25, are the next major catalyst to watch.

Diageo shares climbed almost 2% Friday morning in London, following a stronger mood across European spirits stocks. The rally gained steam after France’s Rémy Cointreau reported sales that beat forecasts, lifting the entire sector.

The move matters because spirits stocks have been riding on shaky confidence: even a small sign of stabilising demand can push prices sharply after months of uncertainty tied to the U.S. and China, two profit hotspots the market still views as fragile.

Diageo’s rebound is on a tight schedule. Investors are eyeing its interim results set for Feb. 25, awaiting management’s take on pricing, inventory levels, and the speed of the recovery.

Diageo (DGE.L) traded at 1,670 pence, rising 32 pence from its last close, according to delayed pricing shortly after the market opened.

Rémy Cointreau reported a 2.8% rise in third-quarter organic sales, excluding currency effects and acquisitions, surpassing expectations. Its shares jumped in early Thursday trading.

“Sentiment on alcohol is so bombed out at the moment that even flickers of improvement can drive big share reactions,” Ryann Dean, a global analyst at Aylett Fund Managers, told Reuters.

Diageo isn’t swayed by a competitor’s strong quarter. In November, it lowered its full-year forecast, warning that fiscal 2026 sales could be flat or even dip slightly. That puts the spotlight firmly on how well it can deliver and drive demand.

China remains a key concern. Reuters reported earlier this month that Diageo is exploring options for its China holdings, including a possible sale, as part of a broader portfolio review.

The risk for bulls is clear-cut: those “green shoots” in the sector might not last. If demand in the U.S. stays patchy or China’s market stays weak, investors could quickly sour on the optimism, sending the stock sliding fast.

Stock Market Today

  • Sensex surges 1,695 points on US-Iran peace talks, crude oil price drop
    June 13, 2026, 2:09 AM EDT. The Sensex jumped 1,695 points to close at 75,528 on Friday, driven by revived US-Iran peace deal talks that sent Dow Jones up over 900 points and Brent crude prices below $90 per barrel. The decline in crude prices eased fears over global supply disruptions, strengthening the rupee to 95.11 against the dollar. Domestic funds bought aggressively, while foreign portfolio investors sold shares worth Rs 1,082 crore. Market cap rose to Rs 462 lakh crore, adding Rs 9.7 lakh crore in investor wealth. Experts highlighted that positive geopolitical developments and lower oil prices improved the near-term outlook for Indian equities. Upcoming US Federal Reserve policy decisions and industrial data will guide markets further.

Latest articles

SGH Limited Holds Back as ASX 200 Pushes Higher Before FY26 Results

SGH Limited Holds Back as ASX 200 Pushes Higher Before FY26 Results

13 June 2026
SGH closed at A$41.51, up 0.70% but underperformed the S&P/ASX 200’s 1.98% surge, as investors weighed solid cash flow and Boral margin gains against a high 36.03 P/E, mixed demand, and M&A risk; the next key catalyst is FY26 results on August 11, with analysts’ average target at A$47.64, 14.76% above Friday’s close.
NCR Voyix Rallies 10% After Investors Shift on Turnaround Bets

NCR Voyix Rallies 10% After Investors Shift on Turnaround Bets

13 June 2026
NCR Voyix soared 10.25% to $7.85, far outpacing the market, as investors focus on the company’s 2026 cash-flow and earnings targets; the next key catalyst is the Q2 2026 earnings update, with stock valuation appearing low if management delivers on margin and cash-flow goals, but risks remain with declining reported revenue and high debt.
GSK share price dips in London as Exdensur rollout and Feb 4 results loom
Previous Story

GSK share price dips in London as Exdensur rollout and Feb 4 results loom

Haleon share price rises in London as HLN stock turns to February results
Next Story

Haleon share price rises in London as HLN stock turns to February results

Go toTop